Daiichi Sankyo

ATIVESITE | Understanding Antibody Drug Conjugates (ADCs)

At Daiichi Sankyo, we create essential medicine for longer, better lives. We are committed to pioneering advancements in #oncology therapy, and our technology aids in the delivery and activity of…

Read More »

ATIVESITE | Where Craft Meets – Partnerships

Daiichi Sankyo’s role in society is to deliver innovative medicines to patients with unmet needs. We believe that to achieve success in any partnership there must be a benefit to…

Read More »

ATIVESITE | How DXd ADCs Came to Be

This video is intended for U.S. HCPs only. In honor of Dr. Toshinori Agatsuma, Executive Officer, Head of Research who was instrumental in the discovery and advancement of the Daiichi…

Read More »

ATIVESITE | Where Craft Meets – Inclusion and Diversity

At Daiichi Sankyo, we’re building a culture of continuous growth, collaboration and learning. Where you can bring your best thinking forward in a way where you are truly valued. In…

Read More »

ATIVESITE | Where Craft Meets – Patients

At Daiichi Sankyo, Passion for Innovation and Compassion for Patients™ is more than a tagline – it’s at the core of everything we do. As Daiichi Sankyo’s Global Head of…

Read More »

ATIVESITE | Where Craft Meets – Medicine

When Dalila Sellami left Tunisia to study medicine in Paris, she promised herself and her home country to return as Tunisia’s first radiation oncologist. Now, as Daiichi Sankyo’s Global Team…

Read More »

ATIVESITE | DXd ADC Technology: Delivering the Potential of ADCs

This video is intended for U.S. HCPs only. Discover the components behind our proprietary DXd ADC Technology that aids in the delivery and activity of the antibody drug conjugates (ADCs)…

Read More »

 

ATIVESITE | Daiichi Sankyo DXd ADC Technology Overview

This video is intended for U.S. HCPs only. At Daiichi Sankyo we aim to create essential medicine for longer, better lives. The core and catalyst behind our oncology development plan…

Read More »

ATIVESITE | Looking Towards the Future of Oncology

This video is intended for U.S. HCPs only. Ken Keller, Global Head of the Daiichi Sankyo #Oncology Business, explores our goals with DXd ADC Technology. We’re on a journey that…

Read More »

ATIVESITE | How DXd ADCs Came to Be

This video is intended for U.S. HCPs only. Advancing ADC technology took scientific expertise, dedication, and a passion for innovation. Take an inside look into the creation of our proprietary…

Read More »